Please check your internet connection and try again.
# Citral
## Overview
Citral is a monoterpene aldehyde found in the oils of many plants, including lemon, lemongrass, and lemon verbena. It is primarily used for its fragrance and flavoring properties.
## Primary Indications
Citral is not a recognized pharmaceutical agent for specific medical indications. Its use is generally limited to cosmetic products and flavorings in food and beverages.
## Adult Dosing
There is no standard pharmaceutical dosing for citral. When used as a flavoring agent, concentrations are typically very low and determined by food industry standards.
## Pediatric Dosing
There is no established pediatric pharmaceutical dosing for citral.
## Dose Adjustments
Not applicable.
## Contraindications
* Known hypersensitivity to citral.
* Should be avoided in individuals with photosensitivity or those prone to allergic reactions to fragrances.
## Adverse Effects
* Skin irritation and allergic contact dermatitis, particularly with prolonged or repeated topical exposure.
* Photosensitivity reactions in susceptible individuals.
* Gastrointestinal upset (nausea, vomiting) with ingestion of high concentrations, though this is unlikely with typical food use.
## Key Drug Interactions
No significant drug interactions are documented for citral in a pharmaceutical context, as it is not typically used systemically.
## Monitoring
Monitoring is generally not required when citral is used in cosmetic or food products at approved concentrations. For topical applications, monitor for signs of skin irritation or allergic reaction.
## Clinical Pearls
Citral is a common component of essential oils used for aromatherapy and fragrance. While generally safe at low concentrations, its potential for skin sensitization should be considered, especially with concentrated topical application.
---
*Disclaimer: This information is intended for clinical pharmacy reference and does not substitute for comprehensive drug information resources. Always verify current prescribing information and institutional protocols before use.*